259 related articles for article (PubMed ID: 31316021)
1. Prognostic Implication of Survivin Expression in Oral Squamous Cell Carcinoma-An Immunohistochemical Study.
Ajithkumar M; Murali CR; Vani NV
J Contemp Dent Pract; 2019 May; 20(5):577-581. PubMed ID: 31316021
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of survivin in oral epithelial dysplasia and different grades of oral squamous cell carcinoma.
Ghritlahare H; Einstein A; Singaraju S; Patel S; Gulati N; Mishra SD
J Oral Maxillofac Pathol; 2022; 26(4):451-457. PubMed ID: 37082058
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of osteopontin expression in oral squamous cell carcinoma.
Jeyasivanesan DL; Mohamed SP; Pandiar D; Basheer S
Indian J Dent Res; 2019; 30(4):539-543. PubMed ID: 31745049
[TBL] [Abstract][Full Text] [Related]
4. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
5. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].
Liu YM; Huang JH; Feng DY; Guo XC
Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of cyclooxygenase-2 in oral squamous cell carcinoma.
Thomas N; Krishnapillai R; Bindhu PR; Thomas P
Indian J Dent Res; 2019; 30(1):102-106. PubMed ID: 30900666
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
9. Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma.
Liu S; Shi L; Yang X; Ye D; Wang T; Dong C; Guo W; Liao Y; Song H; Xu D; Hu J; Zhang Z; Deng J
Cell Cycle; 2017 May; 16(9):894-902. PubMed ID: 28384094
[TBL] [Abstract][Full Text] [Related]
10. Expression of epithelial glycoprotein (EGP40) in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC).
Srichinthu KK; Kumar GS; Prasad H; Rajmohan M; Anuthama K; Yoithapprabhunath TR
Indian J Dent Res; 2020; 31(5):738-742. PubMed ID: 33433512
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study.
Kotrashetti VS; Nayak R; Bhat K; Hosmani J; Somannavar P
Biotech Histochem; 2013 Aug; 88(6):311-22. PubMed ID: 23651260
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of endothelin protein in oral squamous cell carcinoma.
Alaizari NA; Abdelbary SN; Amin NR
Indian J Pathol Microbiol; 2013; 56(2):151-4. PubMed ID: 24056654
[TBL] [Abstract][Full Text] [Related]
13. Analysis of immunohistochemical expression of k19 in oral epithelial dysplasia and oral squamous cell carcinoma using color deconvolution-image analysis method.
Safadi RA; Musleh AS; Al-Khateeb TH; Hamasha AA
Head Neck Pathol; 2010 Dec; 4(4):282-9. PubMed ID: 20882374
[TBL] [Abstract][Full Text] [Related]
14. Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study.
Rajanna VR; Raveendranath MC; Kathiresan S; Srinivasan S; Ilango J
J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S382-S388. PubMed ID: 33149491
[TBL] [Abstract][Full Text] [Related]
15. MUC4 Expression in Oral Dysplastic Epithelium and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Abidullah M; Nahar P; Ahmed SA; Kothari H; Vakeel S
J Int Soc Prev Community Dent; 2023; 13(2):124-132. PubMed ID: 37223448
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation.
Angadi PV; Krishnapillai R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e30-5. PubMed ID: 17197212
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
Zaid KW
Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
[TBL] [Abstract][Full Text] [Related]
18. The study of E-cadherine and CD44 immunoexpression in oral squamous cell carcinoma.
Simionescu C; Mărgăritescu C; Surpăţeanu M; Mogoantă L; Zăvoi R; Ciurea R; Surlin P; Stepan A
Rom J Morphol Embryol; 2008; 49(2):189-93. PubMed ID: 18516325
[TBL] [Abstract][Full Text] [Related]
19. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Survivin as a Prognostic Factor in Squamous-Cell Carcinoma of the Oral Cavity.
Santarelli A; Mascitti M; Rubini C; Bambini F; Giannatempo G; Lo Russo L; Sartini D; Emanuelli M; Procaccini M; Lo Muzio L
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):566-570. PubMed ID: 27389554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
